It was interesting to read the paper by van der Veen and colleagues on the frequency and type of infections in patients with rheumatoid arthritis (RA) treated with methotrexate.' Their experience concurs with that of Antonelli et al2 who concluded that herpes varicella zoster infection in patients with RA receiving methotrexate therapy appears to be self limiting and benign. I wish to report a case of severe and systemic herpes zoster infection in a patient with RA receiving methotrexate.
In April 1994, a 26 year old white woman presented to her general practitioner with a characteristic (but non-pruritic) chicken pox rash. She was receiving methotrexate 20 mg weekly (Fridays), folic acid 20 mg weekly (Tuesdays) One week after she consulted her doctor, the patient's rash had become so generalised and severe that she was admitted to Timaru Hospital. Her mucous membranes (eyes, mouth, and vagina) were also ulcerated (figure). She also had systemic features: general malaise, pyrexia, tachycardia; her blood pressure was always normal. Her full blood count (including a white cell count of 7-9 x 109/1 and differential count) and liver function tests were normal a week before she developed herpes varicella zoster infection. Three days after admission, her white cell count was 23-6 X 109/1 with atypical lymphocytes, characteristic of a viral illness. Her liver function tests were also mildly deranged in a hepatitic pattem and her albumin decreased to 26 mg/l. Five days after admission, she was mildly dyspnoeic and her chest radiographs, which were normal on admission, had developed features consistent with pulmonary alveolitis. Her alveolitis was probably secondary to disseminated varicella infection, although we were mindful of methotrexate induced pneumonitis.
The tongue with candida infection (obscuring the ulcers) and crops ofvaricella vesicles in different stages.
Regular medication with Maxitrol eye drops was started by an ophthalmologist two days before her admission to hospital: all her antirheumatic medications were stopped on admission. She began receiving intravenous hydrocortisone and broadspectrum antibiotics on day 3 of her inpatient treatment. She was also given a course of oral acyclovir although it was later in the course of her infection than was ideal. Supportive therapy including oxygen, analgesia, chlorhexidine and difflam mouth washes, nystatin pastilles, and hypnotics were also given.
Stevens-Johnson Syndrome was considered as a differential diagnosis and attempts were made to confirm the diagnosis of disseminated varicella acutely by electron microscopy of the vesicle fluid and skin scrapings, but it was not possible to identify any varicella virus. Fortunately, the patient's condition gradually improved from day 7 of her admission, and she was able to go home on day 16. At the time of her discharge, the diagnosis of disseminated varicella was confirmed by isolation of the virus on culture of the vesicle fluid and by demonstration of an increase in her varicella serology from a titre of 1/8 to 1/256. Her white cell count, liver function tests and chest radiographs were all normal two weeks after her discharge. When reviewed in the clinic five months later, she was left with some scarring of her skin and ketoprofen alone was sufficient to control her RA symptoms.
Although the patient has made a good recovery, her episode of herpes varicella zoster infection was not benign but lifethreatening. There are two reports3'4 of disseminated zoster in patients with RA receiving methotrexate, but neither indicates any systemic or other organ involvement beyond the skin. Both reports suggest the acute illnesses in these patients were brief. One ofthese patients developed disseminated herpes varicella zoster after beginning steroids while receiving chronic low dose methotrexate.4 The patient reported now was also taking another immunomodulating drug, hydroxychloroquine.
Review of the management of this patient suggests zoster specific immune globulin could have been used had she presented within 96 hours of her contact with a relative who had chicken pox, to reduce the severity of her varicella infection. Had there been a more confident diagnosis of varicella pneumonitis, intravenous rather than oral acyclovir should have been used. 
